Font Size:
a
A
A
Keyword [Non Hodgkin lymphoma]
Result: 121 - 140 | Page: 7 of 8
121.
Analysis Of Clinical Features And Related Influencing Factors Of 285 Cases Of Non-hodgkin's Lymphoma
122.
Clinical Evaluation Of Qinhuang Mixture In The Treatment Of Non-Hodgkin Lymphoma And Its Preliminary Mechanism Study
123.
Clinical Characteristics And Prognosis Of Non-hodgkin's Lymphoma Patients Complicated With Non-hematological Malignant Tumors
124.
The Meta-analysis Of The Association Between Non-Hodgkin Lymphoma And Hepatitis B Virus Infection
125.
The Relationship Between CD68 Expression And Microvessel Density And Beclin-1 In The Microenvironment Of Diffuse Large B-cell Lymphoma
126.
Role Of The Abnormal HIF-Glycolysis-Aerobic Oxidation Pathway In Non-hodgkin Lymphoma And The Intervention Study
127.
Differential Diagnosis Between Indolent And Aggressive Non-Hodgkin Lymphoma And Evaluation Of The Stage:a Pilot Study Of Whole Body Diffusion Weighted Imaging With ADC Value
128.
The Prognostic Significance Of Plasma EBV-DNA Positive In Aggressive Non-Hodgkin Lymphoma
129.
The Clinical Study Of Conventional Ultrasound And Ultrasound Elastography In Diagnosis And Prognosis Of Lymphoma
130.
Clinical Characteristics And Prognosis Of Non-Hodgkin's Lymphoma In Childhood
131.
Hepatitis C Cirrhosis With Non-hodgkin's Lymphoma:A Case Report And Review Of The Literature
132.
A Preliminary Clinical Study Of Multiple Tumor-associated Antigen-specific Cytotoxic T Lymphocytes In The Treatment Of Multiple Myeloma And Non-hodgkin Lymphoma
133.
Expression And Clinical Significance Of BCL-2?BCL-6?C-MYC Proteins In Children With Non-hodgkin's Lymphoma
134.
PI3K ?/? Selective Inhibitor Induces Autophagy And Apoptosis In Non-Hodgkin's Lymphoma
135.
Population Pharmacokinetics Of High-Dose Methotrexate In Adults And Children With Non-Hodgkin Lymphoma
136.
Association of estrogen metabolism and risk of breast or prostate cancer or non-Hodgkin lymphoma: Detection of novel biomarkers from case-control studies
137.
Environment, gene and non-Hodgkin lymphoma survival
138.
Targeting the translational machinery as a novel treatment strategy for non-Hodgkin lymphoma
139.
Fluorescence in situ hybridization (FISH) and risk factors for non-Hodgkin lymphoma (NHL) subtypes defined by t(14;18) translocations and bcl-2 expression
140.
The uses and gratifications of non-Hodgkin lymphoma patients' use of a Facebook group
<<First
<Prev
Next>
Last>>
Jump to